Galapagos | GLPG - Capitale Ordinario

Prezzo Delle Azioni
28.82
Cambio Giornaliero
0.20 0.70%
Mensile
2.27%
Annuale
17.06%
Q1 Previsione
27.72




Capitale Ordinario Cambiamento Data
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Incyte USD 198.46M 2.33M 2025-12
Merck EUR 434.78M 0 2025-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novartis USD 1.94B 23.4M 2025-06
Roche Holding CHF 795.62M 699.54K 2025-12
UCB EUR 584M 0 2024-12
Vertex Pharmaceuticals USD 254M 0 2025-12